Home

Charpentier Réapprovisionnement triathlon her2 marker verbe Privilégié Unité

STAT3 activation in HER2-overexpressing breast cancer promotes  epithelial-mesenchymal transition and cancer stem cell traits
STAT3 activation in HER2-overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits

Spatial proteomic characterization of HER2-positive breast tumors through  neoadjuvant therapy predicts response | Nature Cancer
Spatial proteomic characterization of HER2-positive breast tumors through neoadjuvant therapy predicts response | Nature Cancer

Role of hormone receptors and HER2 as prospective molecular markers for  breast cancer: An update - ScienceDirect
Role of hormone receptors and HER2 as prospective molecular markers for breast cancer: An update - ScienceDirect

Therapeutic targeting of HER2–CB2R heteromers in HER2-positive breast  cancer | PNAS
Therapeutic targeting of HER2–CB2R heteromers in HER2-positive breast cancer | PNAS

Biomarkers for HER2-positive metastatic breast cancer: Beyond hormone  receptors - Cancer Treatment Reviews
Biomarkers for HER2-positive metastatic breast cancer: Beyond hormone receptors - Cancer Treatment Reviews

HER2 induced EMT and tumorigenicity in breast epithelial progenitor cells  is inhibited by coexpression of EGFR | Oncogene
HER2 induced EMT and tumorigenicity in breast epithelial progenitor cells is inhibited by coexpression of EGFR | Oncogene

Clinical and molecular characteristics of HER2-low-positive breast cancer:  pooled analysis of individual patient data from four prospective,  neoadjuvant clinical trials - The Lancet Oncology
Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials - The Lancet Oncology

Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in  colorectal cancer - Annals of Oncology
Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in colorectal cancer - Annals of Oncology

A novel HER2-targeting antibody 5G9 identified by large-scale  trastuzumab-based screening exhibits potent synergistic antitumor activity  - eBioMedicine
A novel HER2-targeting antibody 5G9 identified by large-scale trastuzumab-based screening exhibits potent synergistic antitumor activity - eBioMedicine

Essential role of the cancer stem/progenitor cell marker nucleostemin for  indole-3-carbinol anti-proliferative responsiveness in human breast cancer  cells | BMC Biology | Full Text
Essential role of the cancer stem/progenitor cell marker nucleostemin for indole-3-carbinol anti-proliferative responsiveness in human breast cancer cells | BMC Biology | Full Text

HER2 status in breast Cancer: What does it mean? - Moose and Doc
HER2 status in breast Cancer: What does it mean? - Moose and Doc

Multi-omics analyses identify HSD17B4 methylation-silencing as a predictive  and response marker of HER2-positive breast cancer to HER2-directed therapy  | Scientific Reports
Multi-omics analyses identify HSD17B4 methylation-silencing as a predictive and response marker of HER2-positive breast cancer to HER2-directed therapy | Scientific Reports

Overexpression of HER2 in the pancreas promotes development of intraductal  papillary mucinous neoplasms in mice | Scientific Reports
Overexpression of HER2 in the pancreas promotes development of intraductal papillary mucinous neoplasms in mice | Scientific Reports

Multi-omics analyses identify HSD17B4 methylation-silencing as a predictive  and response marker of HER2-positive breast cancer to HER2-directed therapy  | Scientific Reports
Multi-omics analyses identify HSD17B4 methylation-silencing as a predictive and response marker of HER2-positive breast cancer to HER2-directed therapy | Scientific Reports

Clinical applications of mouse models for breast cancer engaging HER2/neu
Clinical applications of mouse models for breast cancer engaging HER2/neu

Nuclear Y-Box Binding Protein-1, a Predictive Marker of Prognosis, Is  Correlated with Expression of HER2/ErbB2 and HER3/ErbB3 in Non-small Cell  Lung Cancer - Journal of Thoracic Oncology
Nuclear Y-Box Binding Protein-1, a Predictive Marker of Prognosis, Is Correlated with Expression of HER2/ErbB2 and HER3/ErbB3 in Non-small Cell Lung Cancer - Journal of Thoracic Oncology

Detection of cancer marker Her2 with QD-IgG.(A, C) Fixed breast cancer... |  Download Scientific Diagram
Detection of cancer marker Her2 with QD-IgG.(A, C) Fixed breast cancer... | Download Scientific Diagram

PLOS ONE: Serum HER2 Level Measured by Dot Blot: A Valid and Inexpensive  Assay for Monitoring Breast Cancer Progression
PLOS ONE: Serum HER2 Level Measured by Dot Blot: A Valid and Inexpensive Assay for Monitoring Breast Cancer Progression

IVD Antibody & Immunoassay Development Services for HER2 Biomarker -  Creative Biolabs
IVD Antibody & Immunoassay Development Services for HER2 Biomarker - Creative Biolabs

Immunohistochemical profiles of ER, PR, HER2 and Ki-67 markers in the... |  Download Scientific Diagram
Immunohistochemical profiles of ER, PR, HER2 and Ki-67 markers in the... | Download Scientific Diagram

Aberrant Expression of Novel and Previously Described Cell Membrane Markers  in Human Breast Cancer Cell Lines and Tumors | Clinical Cancer Research
Aberrant Expression of Novel and Previously Described Cell Membrane Markers in Human Breast Cancer Cell Lines and Tumors | Clinical Cancer Research

Breast cancer: a new target? | Recherche animale
Breast cancer: a new target? | Recherche animale

Cancers | Free Full-Text | HER2 Signaling and Breast Cancer Stem Cells: The  Bridge behind HER2-Positive Breast Cancer Aggressiveness and Therapy  Refractoriness | HTML
Cancers | Free Full-Text | HER2 Signaling and Breast Cancer Stem Cells: The Bridge behind HER2-Positive Breast Cancer Aggressiveness and Therapy Refractoriness | HTML

Recognition of HER2 expression in hepatocellular carcinoma and its  significance in postoperative tumor recurrence - Shi - 2019 - Cancer  Medicine - Wiley Online Library
Recognition of HER2 expression in hepatocellular carcinoma and its significance in postoperative tumor recurrence - Shi - 2019 - Cancer Medicine - Wiley Online Library

Addgene: pcDNA3-HER2-DMVF-181-N
Addgene: pcDNA3-HER2-DMVF-181-N

Breast cancer: a new target? | Recherche animale
Breast cancer: a new target? | Recherche animale

HER2 overexpression induced pSTAT3 and stem cell marker expression in... |  Download Scientific Diagram
HER2 overexpression induced pSTAT3 and stem cell marker expression in... | Download Scientific Diagram